Skip to main content
Smart Investors Daily
MR

OTC · MRMD

MariMed Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

$0.07

Up+$0.00 (+3.01%)

Updated Aug 14, 2026, 7:25 AM

SID Score

4.4/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
29.63M
P/E ratio
-1.84
Dividend yield
0.00%
52-week range
— – —
Volume
104.09K
Avg. volume
1.2M

Price performance

MRMD price history

1M range · 0 trading sessions · Daily adjusted prices

MRMD does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest MRMD news

The latest Smart Investors Daily articles mentioning MRMD.

MRMD research

Overview

Company profile and research snapshot.

Company profile

MARIMED INC

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
$2.25
Implied upside
Analysts
MRMD recent ratings
DateFirmRatingTarget
Nov 6, 2023Zuanic & AssociatesOverweight
Oct 28, 2022BTIGBuy
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Jan 22, 2026

MariMed Launches Hemp-Derived THC Products Under its Vibations™ Brand in Rhode Island

NORWOOD, Mass., Jan. 22, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed,” “the Company”) (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced the launch of a hemp-derived THC version of its Vibations™ hydrating drink mix brand in Rhode Island. The launch represents a capital-efficient opportunity for the Company to expand Vibations into the rapidly growing hemp THC beverage category through an established retail channel, without incremental

Yahoo · Dec 8, 2025

Veterans Healing Journey Becomes Soundtrack of Thrive Dispensaries

MariMed Debuts Original Song Inspired by a U.S. Army Veteran’s Experience, Supporting FreedomSingsUSA, and Strengthening its Commitment to Veteran-Focused InitiativesNORWOOD, Mass., Dec. 08, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. (“MariMed”) (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator committed to improving lives every day, today announced an inspiring new initiative sparked by U.S. Army veteran and MariMed dispensary customer Ryan Taylor. After years of battling the physic

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.